Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0348321 (Haemophilus)
 15,372 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The biological fate of temperate phage HP1 deoxyribonucleic acid (DNA) was followed after uptake by defectively lysogenic competent Haemophilus influenzae cultures. The similar inactivation kinetics of three single phage genetic markers and of their triple combination indicated a complete rather than partial destruction of about half of the adsorbed DNA molecules. Intracellular DNA breakdown products were tentatively identified by hydroxyapatite column chromatography as short single strands and extensively damaged short double strands. Integrated donor DNA (after single-strand insertion?) was still highly efficient for triple-marker co-transformation. This suggests that whole or nearly whole donor DNA molecules were integrated. Some donor DNA was never integrated but remained largely unaltered. This DNA fraction did not contain significant amounts of recipient prophage marker activity. It is concluded that it had not participated in some kind of reciprocal recombination event involving the recipient chromosome. Since very similar phage DNA marker inactivation rates were observed after adsorption by competent nonlysogenic recipients (transfection), the relationship between biological inactivation of adsorbed donor phage DNA and its integration in lysogenic recipients is not clear.
 ...
PMID:Fate of transforming bacteriophage HP1 deoxyribonucleic acid in Haemophilus influenzae lysogens. 108 Jan 48

Health is one of the most important contributors to animal welfare, productivity and profitability in pig production today. For the past 30 years, pig breeders have focused on genetic improvement of lean growth, feed efficiency, meat quality and reproduction. However, in recent years, selection objectives have been broadened to include livability, robustness and disease resistance. A DNA marker for selection of resistance to F18+ E. coli has been available for several years. This marker decreases mortality and improves growth on farms experiencing post-weaning scours and/or oedema disease. However, for most diseases affecting intensive production systems such as porcine reproductive and respiratory syndrome (PRRS), porcine circovirus type 2-associated diseases (PCVAD), Haemophilus parasuis, and swine influenza virus, resistance is a complex and polygenic trait. Selection for improved resistance to these diseases will be incremental and require use of multiple markers in complex breeding schemes. Novel technologies such as pig gene microarrays, single nucleotide polymorphism (SNP) panels and advanced bioinformatics are being used to identify new health candidate genes for these economically important diseases. Lagging behind, however, is availability of large DNAdatasets from pedigreed populations with accurately measured health phenotypes that are needed to identify associations between SNPs and health traits. Increased focus on datasets with health traits will be the key to finding useable discoveries with new genomics technologies. Currently, the industry uses dozens of SNP markers to increase the accuracy of selection for complex breeding objectives, including disease resistance. As the pig genome is sequenced and barriers to genotyping thousand of markers are eliminated, genomic selection for health traits will receive increasing attention from commercial breeders.
 ...
PMID:Improving pig health through genomics: a view from the industry. 1881 84